91.33 -0.08 (-0.09%) | 02-18 16:00 | |||||||||||||
|
|
Short term | ![]() |
|||
Mid term | ![]() |
|||
Targets | 6-month : | 110.84 | 1-year : | 129.46 |
Resists | First : | 94.9 | Second : | 110.84 |
Pivot price | 91.87 ![]() |
|||
Supports | First : | 89.64 | Second : | 86.4 |
MAs | MA(5) : | 90.51 ![]() |
MA(20) : | 91.89 ![]() |
MA(100) : | 95.21 ![]() |
MA(250) : | 94.65 ![]() |
|
MACD | MACD : | -0.4 ![]() |
Signal : | -0.3 ![]() |
%K %D | K(14,3) : | 46.8 ![]() |
D(3) : | 37.7 ![]() |
RSI | RSI(14): 48.8 ![]() |
|||
52-week | High : | 105.47 | Low : | 81.13 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ XBI ] has closed above bottom band by 41.1%. Bollinger Bands are 27.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 93.17 - 93.65 | 93.65 - 94.01 |
Low: | 89.86 - 90.36 | 90.36 - 90.75 |
Close: | 90.56 - 91.4 | 91.4 - 92.04 |
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").
Fri, 14 Feb 2025
Is SPDR S&P Software & Services ETF (XSW) a Strong ETF Right Now? - MSN
Thu, 13 Feb 2025
Should You Invest in the SPDR S&P Homebuilders ETF (XHB)? - MSN
Wed, 05 Feb 2025
Should You Invest in the SPDR S&P Aerospace & Defense ETF (XAR)? - TradingView
Fri, 10 Jan 2025
Best SPDR ETFs to Buy and Hold - Kiplinger's Personal Finance
Tue, 31 Dec 2024
Is SPY Losing Its Spark? The S&P 500's Risk Conundrum - SPDR S&P 500 (ARCA:SPY) - Benzinga
Fri, 06 Dec 2024
Is SPDR Portfolio S&P 500 High Dividend ETF (SPYD) a Strong ETF Right Now? - Yahoo Finance
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
AMEX
|
|
Sector:
Financial Services
|
|
Industry:
Asset Management
|
|
Shares Out | 0 (M) |
Shares Float | 0 (M) |
Held by Insiders | 0 (%) |
Held by Institutions | 0 (%) |
Shares Short | 0 (K) |
Shares Short P.Month | 0 (K) |
EPS | 0 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0 |
Profit Margin | 0 % |
Operating Margin | 0 % |
Return on Assets (ttm) | 0 % |
Return on Equity (ttm) | 0 % |
Qtrly Rev. Growth | 0 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | 0 (M) |
PE Ratio | 0 |
PEG Ratio | 0 |
Price to Book value | 0 |
Price to Sales | 0 |
Price to Cash Flow | 0 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |